{"result": "(\"entity\"<|>VAGINAL CANCER<|>EVENT<|>Vaginal Cancer is a type of disease characterized by various symptoms and localizations in the human body.)\n##\n(\"entity\"<|>AGEUSIA<|>EVENT<|>Ageusia is a symptom associated with Vaginal Cancer, indicating a loss of taste sensation.)\n##\n(\"entity\"<|>AGNOSIA<|>EVENT<|>Agnosia is a symptom associated with Vaginal Cancer, indicating an inability to recognize objects or people.)\n##\n(\"entity\"<|>AMBYLOPIA<|>EVENT<|>Amblyopia is a symptom associated with Vaginal Cancer, often referred to as \"lazy eye,\" affecting vision.)\n##\n(\"entity\"<|>ANOREXIA<|>EVENT<|>Anorexia is a symptom associated with Vaginal Cancer, characterized by a loss of appetite.)\n##\n(\"entity\"<|>OLFACATION DISORDERS<|>EVENT<|>Olfaction Disorders are symptoms associated with Vaginal Cancer, indicating issues with the sense of smell.)\n##\n(\"entity\"<|>ANOXIA<|>EVENT<|>Anoxia is a symptom associated with Vaginal Cancer, indicating a deficiency in the amount of oxygen reaching the tissues.)\n##\n(\"entity\"<|>APHASIA<|>EVENT<|>Aphasia is a symptom associated with Vaginal Cancer, indicating a loss of ability to understand or express speech.)\n##\n(\"entity\"<|>APHASIA, WERNICKE<|>EVENT<|>Wernicke's Aphasia is a specific type of aphasia associated with Vaginal Cancer, affecting language comprehension.)\n##\n(\"entity\"<|>APHONIA<|>EVENT<|>Aphonia is a symptom associated with Vaginal Cancer, indicating a loss of voice or ability to speak.)\n##\n(\"entity\"<|>APNEA<|>EVENT<|>Apnea is a symptom associated with Vaginal Cancer, indicating temporary cessation of breathing.)\n##\n(\"entity\"<|>UTERINE CERVIX<|>GEO<|>The Uterine Cervix is a location in the human body where Vaginal Cancer can localize.)\n##\n(\"entity\"<|>NOSE<|>GEO<|>The Nose is a location in the human body where Vaginal Cancer can localize.)\n##\n(\"entity\"<|>LYMPH NODE<|>GEO<|>The Lymph Node is a location in the human body where Vaginal Cancer can localize.)\n##\n(\"entity\"<|>HEAD<|>GEO<|>The Head is a location in the human body where Vaginal Cancer can localize.)\n##\n(\"entity\"<|>GANGLION<|>GEO<|>The Ganglion is a location in the human body where Vaginal Cancer can localize.)\n##\n(\"entity\"<|>MACULA<|>GEO<|>The Macula is a location in the human body where Vaginal Cancer can localize.)\n##\n(\"entity\"<|>URETER<|>GEO<|>The Ureter is a location in the human body where Vaginal Cancer can localize.)\n##\n(\"entity\"<|>URETHRA<|>GEO<|>The Urethra is a location in the human body where Vaginal Cancer can localize.)\n##\n(\"entity\"<|>MOUTH<|>GEO<|>The Mouth is a location in the human body where Vaginal Cancer can localize.)\n##\n(\"entity\"<|>FEMALE REPRODUCTIVE SYSTEM<|>GEO<|>The Female Reproductive System is a location in the human body where Vaginal Cancer can localize.)\n##\n(\"entity\"<|>PILOCARPINE<|>ORGANIZATION<|>Pilocarpine is a cholinergic muscarinic agonist compound that can palliate Vaginal Cancer.)\n##\n(\"entity\"<|>ETOPOSIDE<|>ORGANIZATION<|>Etoposide is a topoisomerase inhibitor compound that can treat Vaginal Cancer.)\n##\n(\"entity\"<|>ALITRETINOIN<|>ORGANIZATION<|>Alitretinoin is a retinoid compound that can treat Vaginal Cancer.)\n##\n(\"entity\"<|>ISOTRETINOIN<|>ORGANIZATION<|>Isotretinoin is a retinoid compound that can treat Vaginal Cancer.)\n##\n(\"entity\"<|>HYDROXYUREA<|>ORGANIZATION<|>Hydroxyurea is a urea compound that can treat Vaginal Cancer.)\n##\n(\"entity\"<|>TRETINOIN<|>ORGANIZATION<|>Tretinoin is a retinoid compound that can treat Vaginal Cancer.)\n##\n(\"entity\"<|>VINBLASTINE<|>ORGANIZATION<|>Vinblastine is a vinca alkaloid compound that can treat Vaginal Cancer.)\n##\n(\"entity\"<|>DOXORUBICIN<|>ORGANIZATION<|>Doxorubicin is a topoisomerase inhibitor compound that can treat Vaginal Cancer.)\n##\n(\"entity\"<|>DACARBAZINE<|>ORGANIZATION<|>Dacarbazine is an alkylating activity compound that can treat Vaginal Cancer.)\n##\n(\"entity\"<|>CISPLATIN<|>ORGANIZATION<|>Cisplatin is a platinum-containing compound that can treat Vaginal Cancer.)\n##\n(\"entity\"<|>FLUOROURACIL<|>ORGANIZATION<|>Fluorouracil is a nucleic acid synthesis inhibitor compound that can treat Vaginal Cancer.)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>AGEUSIA<|>Ageusia is a symptom presented by Vaginal Cancer<|>8)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>AGNOSIA<|>Agnosia is a symptom presented by Vaginal Cancer<|>8)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>AMBYLOPIA<|>Amblyopia is a symptom presented by Vaginal Cancer<|>8)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>ANOREXIA<|>Anorexia is a symptom presented by Vaginal Cancer<|>8)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>OLFACATION DISORDERS<|>Olfaction Disorders are symptoms presented by Vaginal Cancer<|>8)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>ANOXIA<|>Anoxia is a symptom presented by Vaginal Cancer<|>8)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>APHASIA<|>Aphasia is a symptom presented by Vaginal Cancer<|>8)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>APHASIA, WERNICKE<|>Wernicke's Aphasia is a symptom presented by Vaginal Cancer<|>8)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>APHONIA<|>Aphonia is a symptom presented by Vaginal Cancer<|>8)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>APNEA<|>Apnea is a symptom presented by Vaginal Cancer<|>8)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>UTERINE CERVIX<|>Vaginal Cancer localizes at the Uterine Cervix<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>NOSE<|>Vaginal Cancer localizes at the Nose<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>LYMPH NODE<|>Vaginal Cancer localizes at the Lymph Node<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>HEAD<|>Vaginal Cancer localizes at the Head<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>GANGLION<|>Vaginal Cancer localizes at the Ganglion<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>MACULA<|>Vaginal Cancer localizes at the Macula<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>URETER<|>Vaginal Cancer localizes at the Ureter<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>URETHRA<|>Vaginal Cancer localizes at the Urethra<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>MOUTH<|>Vaginal Cancer localizes at the Mouth<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>FEMALE REPRODUCTIVE SYSTEM<|>Vaginal Cancer localizes at the Female Reproductive System<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>PILOCARPINE<|>Pilocarpine can palliate Vaginal Cancer<|>7)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>ETOPOSIDE<|>Etoposide can treat Vaginal Cancer<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>ALITRETINOIN<|>Alitretinoin can treat Vaginal Cancer<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>ISOTRETINOIN<|>Isotretinoin can treat Vaginal Cancer<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>HYDROXYUREA<|>Hydroxyurea can treat Vaginal Cancer<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>TRETINOIN<|>Tretinoin can treat Vaginal Cancer<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>VINBLASTINE<|>Vinblastine can treat Vaginal Cancer<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>DOXORUBICIN<|>Doxorubicin can treat Vaginal Cancer<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>DACARBAZINE<|>Dacarbazine can treat Vaginal Cancer<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>CISPLATIN<|>Cisplatin can treat Vaginal Cancer<|>9)\n##\n(\"relationship\"<|>VAGINAL CANCER<|>FLUOROURACIL<|>Fluorouracil can treat Vaginal Cancer<|>9)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: [Vaginal Cancer] is the name of a kind of disease.\n[Vaginal Cancer] presents the symptom [Ageusia].\n[Vaginal Cancer] presents the symptom [Agnosia].\n[Vaginal Cancer] presents the symptom [Amblyopia].\n[Vaginal Cancer] presents the symptom [Anorexia].\n[Vaginal Cancer] presents the symptom [Olfaction Disorders].\n[Vaginal Cancer] presents the symptom [Anoxia].\n[Vaginal Cancer] presents the symptom [Aphasia].\n[Vaginal Cancer] presents the symptom [Aphasia, Wernicke].\n[Vaginal Cancer] presents the symptom [Aphonia].\n[Vaginal Cancer] presents the symptom [Apnea].\n[Vaginal Cancer] localizes at the [Uterine Cervix] of human body.\n[Vaginal Cancer] localizes at the [Nose] of human body.\n[Vaginal Cancer] localizes at the [Lymph Node] of human body.\n[Vaginal Cancer] localizes at the [Head] of human body.\n[Vaginal Cancer] localizes at the [Ganglion] of human body.\n[Vaginal Cancer] localizes at the [Macula] of human body.\n[Vaginal Cancer] localizes at the [Ureter] of human body.\n[Vaginal Cancer] localizes at the [Urethra] of human body.\n[Vaginal Cancer] localizes at the [Mouth] of human body.\n[Vaginal Cancer] localizes at the [Female Reproductive System] of human body.\n\nThe following content describes information about compounds that can palliate or treat the disease named Vaginal Cancer.The format of each compound's information is as follows:\nCompound name: ***\nPharmacologic class: ***\nEffect on Vaginal Cancer: Palliate or Treat\nSide effect: ***\nThese respectively represent the name of the compound, the pharmacologic class it belongs to, its positive effect on the disease named Vaginal Cancer (palliates or treats) and its side effects.\n\nCompound name: Pilocarpine\nPharmacologic class: Cholinergic Muscarinic Agonists\nEffect on Vaginal Cancer: Palliate\nSide effect: Abdominal pain, Congenital anomaly, Alopecia, Amblyopia, Angina pectoris, Anorexia, Anxiety, Aphasia, Arrhythmia, Arthralgia\n\nCompound name: Etoposide\nPharmacologic class: Topoisomerase Inhibitors\nEffect on Vaginal Cancer: Treat\nSide effect: Abdominal pain, Agranulocytosis, Alopecia, Anaphylactic shock, Anaemia, Anorexia, Apnoea, Ascites, Asthenia, Back pain\n\nCompound name: Alitretinoin\nPharmacologic class: Retinoids\nEffect on Vaginal Cancer: Treat\nSide effect: Abdominal distension, Abdominal pain, Acidosis, Acquired immunodeficiency syndrome, Pancreatitis acute, Aggression, Agnosia, Agranulocytosis, Alopecia, Anaphylactic shock\n\nCompound name: Isotretinoin\nPharmacologic class: Retinoids\nEffect on Vaginal Cancer: Treat\nSide effect: Abdominal distension, Abdominal pain, Acidosis, Acquired immunodeficiency syndrome, Pancreatitis acute, Aggression, Agnosia, Agranulocytosis, Alopecia, Anaphylactic shock\n\nCompound name: Hydroxyurea\nPharmacologic class: Urea\nEffect on Vaginal Cancer: Treat\nSide effect: Alopecia, Amenorrhoea, Anaemia, Anaemia megaloblastic, Anorexia, Asthenia, Azoospermia, Blepharitis, Blister, Breast disorder\n\nCompound name: Tretinoin\nPharmacologic class: Retinoids\nEffect on Vaginal Cancer: Treat\nSide effect: Abdominal distension, Abdominal pain, Acidosis, Acquired immunodeficiency syndrome, Pancreatitis acute, Aggression, Agnosia, Agranulocytosis, Alopecia, Anaphylactic shock\n\nCompound name: Vinblastine\nPharmacologic class: Vinca Alkaloids\nEffect on Vaginal Cancer: Treat\nSide effect: Abdominal pain, Agranulocytosis, Alopecia, Anaemia, Angina pectoris, Anorexia, Asthenia, Cellulitis, Constipation, Deafness\n\nCompound name: Doxorubicin\nPharmacologic class: Topoisomerase Inhibitors\nEffect on Vaginal Cancer: Treat\nSide effect: Abdominal distension, Abdominal pain, Abscess, Lactic acidosis, Agranulocytosis, Albuminuria, Alopecia, Amblyopia, Amenorrhoea, Anaphylactic shock\n\nCompound name: Dacarbazine\nPharmacologic class: Alkylating Activity\nEffect on Vaginal Cancer: Treat\nSide effect: \n\nCompound name: Cisplatin\nPharmacologic class: Platinum-containing Compounds\nEffect on Vaginal Cancer: Treat\nSide effect: Abscess, Alopecia, Amnesia, Anaphylactic shock, Anaemia, Haemolytic anaemia, Anorexia, Anxiety, Arrhythmia, Asthenia\n\nCompound name: Fluorouracil\nPharmacologic class: Nucleic Acid Synthesis Inhibitors\nEffect on Vaginal Cancer: Treat\nSide effect: Congenital anomaly, Abortion spontaneous, Agranulocytosis, Alopecia, Amnesia,\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}